Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: The Guanacaste project

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 1, Issue 5, 1997, Pages 362-375

  Herrero, Rolando ^a,b,c   Schiffman, Mark H ^c   Bratti, Concepción ^b   Hildesheim, Allan ^c   Balmaceda, Ileana ^d   Sherman, Mark E ^e   Greenberg, Mitchell ^f   Cárdenas, Fernando ^d   Gómez, Victor ^d   Helgesen, Kay ^g   Morales, Jorge ^d   Hutchinson, Martha ^h   Mango, Laurie ⁱ   Alfaro, Mario ^d   Potischman, Nancy W ^c   Wacholder, Sholom ^c   Swanson, Christine ^c   Brinton, Louise A ^c  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Ministerio de Salud   (Costa Rica)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CAJA COSTARRICENSE DE SEGURO SOCIAL   (Costa Rica)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GRADUATE HOSPITAL   (United States)

^g INFORMATION MANAGEMENT SERVICES INC   (United States)

^h TUFTS UNIVERSITY   (United States)

ⁱ Neuromedical Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; COSTA RICA; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; METHODOLOGY; PH; POPULATION RESEARCH; RURAL AREA; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 0030850686     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49891997000500005     Document Type: Article

References (23)

1. Pisani P, Parkin DM, Muñoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction for 1990. Cancer Epidemiol Biomarkers Prev [in press].
2. Beral V. Cancer of the cervix: a sexually transmitted infection? Lancet 1974;110:37-40.
3. Brinton LA, Hamman RF, Huggins GR. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 1987;79:23-30.
4. Herrero R, Brinton LA, Reeves WC, Brenes MM, Tenorio F, de Britton RC, et al. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population. Cancer 1990;65:380-386.
5. International Agency for Research on Cancer (IARC). Monograph on the evaluation of carcinogenic risks to humans: human papillomaviruses. Lyon, France: IARC; 1995. (IARC Scientific publications, Vol 64).
6. Dillner J. Immunobiology of papillomavirus; prospects for vaccination. Cancer J 1992;5(4): 181-187.
7. Brinton LA, Reeves WC, Brenes MM, Herrero R, Gaitan E, Garcia M, et al. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989;130(3):486-496.
8. Brinton LA, Herrero R, Brenes MM, Montalvan P, de la Guardia ME, Avila A, et al. Considerations for conducting epidemiologic case-control studies of cancer in developing countries. Bull Pan Am Health Organ 1991; 25(1):1-15.
9. Reeves WC, Brinton LA, Garcia M, Brenes MM, Herrero R, Gaitan E, et al. Human papillomavirus (HPV) infection and cervical cancer in Latin America. N Eng J Med 1989;320: 1347-1441.
10. Herrero R, Brinton LA, Reeves WC, Brenes MM, Tenorio F, de Britton RC, et al. Risk factors for invasive carcinoma of the uterine cervix in Latin America. Bull Pan Am Health Organ 1990;24(3):263-283.
11. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-964.
12. Krüger Kjaer S, van der Brule AJC, Bock JE, et al. Human papillomavirus - The most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996;65(5):601-606.
13. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walboomers JMM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994;69:114-120.
14. Munoz N, Bosch FX, de San Jose S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992;52:743-749.
15. Parkin DM, Muir CS, Whelam SL, et al. (eds.) Cancer incidence in five continents, Volume VI. Lyon, France: IARC; 1992. (IARC Scientific publications, number 120).
16. Ries LAG, Miller BA, Hankey BF. (eds.) SEER Cancer Statistics Review: 1973-1991. Bethesda, MD: National Cancer Institute; 1994. (NIH Pub. 94-2789).
17. Herrero R, Hartge P, Brinton LA, Reeves WC, Brenes MM, Urcuyo R, et al. Determinants of the geographic variation of invasive cervical 5 cancer in Costa Rica. Bull Pan Am Health Organ 1993;27(1):15-25.
18. Ferris DG, Berrey MM, Ellis KE, Petry LJ, Voxnaes J, Beatie RT. The optimal technique for obtaining a Papanicolaou smear with the Cervex brush. J Fam Pract 1992;34:276-280.
19. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA 1989; 262:931-934.
20. Reid R, Herschman BR. A colposcopic index for differentiating subclinical papilloma viral infection from cervical intraepithelial neoplasia. Am J Obstet Gynecol 1984;149:815.
21. Schiffman MH, Kiviat N, Burk RD, Shah K, Daniel R, Lewis R, et al. Accuracy and interlaboratory reliability of HPV DNA testing by hybrid capture. J Clin Microbiol 1995;33: 545-550.
22. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-337.
23. Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 1993;20:279-285.